Drug profile · INN
rotigotine
NEUPRO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
rotigotine (NEUPRO) is an FDA-listed pharmaceutical active ingredient. Route of administration: transdermal. Current US regulatory status: approved.
Key facts
INN rotigotine
Brand NEUPRO
Route TRANSDERMAL
Formulation FILM, EXTENDED RELEASE
ATC code N04BC09
Frequently asked questions
What is rotigotine?
rotigotine (NEUPRO) is an FDA-listed pharmaceutical active ingredient. Route of administration: transdermal. Current US regulatory status: approved.
What is the brand name for rotigotine?
NEUPRO is a marketed brand name for rotigotine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of rotigotine?
rotigotine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.